Deutsche Bank raised the firm’s price target on Novartis (NVS) to CHF 120 from CHF 115 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
- Pan-Tumor Rollover Study: A New Horizon in Long-term Cancer Treatment
- Novartis and Olema’s Phase 1b Breast Cancer Study: Market Watch
- Trump Trade: Pharma tariff announcement likely ‘weeks away’
- Pharma tariff announcement likely ‘weeks away,’ Reuters reports